Although well-established as Asia’s leading financial services and trading hub, Hong Kong has never truly been globally competitive in the…

While much of PharmaBoardroom's recent report on Hong Kong and the Greater Bay Area looks at how Hong Kong is attempting to position itself as a…

Hong Kong provides some of the best and most efficient healthcare in Asia, with Hong Kongers living to over 85 on average (compared to 83 in Singapore…

A decade on from its launch, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative has made some significant wins but remains some way from…

2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to…

Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons,…

Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within…

Ongoing geopolitical tensions between China and the West have led the G7 group of countries to warn of the threat of “economic coercion” from…

Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on…

Novartis, one of the world's largest biopharma companies, has secured approval and market access for two of its most advanced cell and gene treatments…

Generative Artificial Intelligence (AI) has grabbed a lot of media attention in recent months following the launch of chatbot ChatGPT, but the…

One of Asia's most pre-eminent oncologists, Professor Tony Mok is perhaps best known for discovering the EGFR mutation gene and subsequently…